Literature DB >> 31494079

Longitudinal analysis of dementia diagnosis and specialty care among racially diverse Medicare beneficiaries.

Emmanuel Fulgence Drabo1, Douglas Barthold2, Geoffrey Joyce3, Patricia Ferido4, Helena Chang Chui5, Julie Zissimopoulos6.   

Abstract

INTRODUCTION: There is insufficient understanding of diagnosis of etiologic dementia subtypes and contact with specialized dementia care among older Americans.
METHODS: We quantified dementia diagnoses and subsequent health care over five years by etiologic subtype and physician specialty among Medicare beneficiaries with incident dementia diagnosis in 2008/09 (226,604 persons/714,015 person-years).
RESULTS: Eighty-five percent of people were diagnosed by a nondementia specialist physician. Use of dementia specialists within one year (22%) and five years (36%) of diagnosis was low. "Unspecified" dementia diagnosis was common, higher among those diagnosed by nondementia specialists (33.2%) than dementia specialists (21.6%). Half of diagnoses were Alzheimer's disease. DISCUSSION: Ascertainment of etiologic dementia subtype may inform hereditary risk and facilitate financial and care planning. Use of dementia specialty care was low, particularly for Hispanics and Asians, and associated with more detection of etiological subtype. Dementia-related professional development for nonspecialists is urgent given their central role in dementia diagnosis and care.
Copyright © 2019 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Dementia specialist; Dementia subtype; Diagnosis; Disparities; Unspecified dementia

Mesh:

Year:  2019        PMID: 31494079      PMCID: PMC6874742          DOI: 10.1016/j.jalz.2019.07.005

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  37 in total

1.  Medscape's response to the Institute of Medicine Report: Crossing the quality chasm: a new health system for the 21st century.

Authors:  M Leavitt
Journal:  MedGenMed       Date:  2001-03-05

2.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 3.  Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors.

Authors:  Andrea Bradford; Mark E Kunik; Paul Schulz; Susan P Williams; Hardeep Singh
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Oct-Dec       Impact factor: 2.703

4.  Glaucoma, Alzheimer disease and other dementia: a longitudinal analysis.

Authors:  Yvonne Ou; Daniel S Grossman; Paul P Lee; Frank A Sloan
Journal:  Ophthalmic Epidemiol       Date:  2012-10       Impact factor: 1.648

5.  Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-06-03       Impact factor: 25.391

6.  Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study.

Authors:  Mindy J Katz; Richard B Lipton; Charles B Hall; Molly E Zimmerman; Amy E Sanders; Joe Verghese; Dennis W Dickson; Carol A Derby
Journal:  Alzheimer Dis Assoc Disord       Date:  2012 Oct-Dec       Impact factor: 2.703

7.  Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting.

Authors:  Cyndy B Cordell; Soo Borson; Malaz Boustani; Joshua Chodosh; David Reuben; Joe Verghese; William Thies; Leslie B Fried
Journal:  Alzheimers Dement       Date:  2012-12-20       Impact factor: 21.566

8.  The Impact of Changes in Population Health and Mortality on Future Prevalence of Alzheimer's Disease and Other Dementias in the United States.

Authors:  Julie M Zissimopoulos; Bryan C Tysinger; Patricia A St Clair; Eileen M Crimmins
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2018-04-16       Impact factor: 4.942

9.  Assessing the economic burden of Alzheimer's disease patients first diagnosed by specialists.

Authors:  Noam Y Kirson; Urvi Desai; Ljubica Ristovska; Alice Kate G Cummings; Howard G Birnbaum; Wenyu Ye; J Scott Andrews; Daniel Ball; Kristin Kahle-Wrobleski
Journal:  BMC Geriatr       Date:  2016-07-11       Impact factor: 3.921

Review 10.  Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges.

Authors:  Bruno Dubois; Alessandro Padovani; Philip Scheltens; Andrea Rossi; Grazia Dell'Agnello
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

View more
  20 in total

1.  Changes in Health Care Use by Mexican American Medicare Beneficiaries Before and After a Diagnosis of Dementia.

Authors:  Brian Downer; Soham Al Snih; Lin-Na Chou; Yong-Fang Kuo; Mukaila Raji; Kyriakos S Markides; Kenneth J Ottenbacher
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-02-25       Impact factor: 6.053

2.  Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis.

Authors:  Sebastian E Sattui; Mangala Rajan; Sarah B Lieber; Geyanne Lui; Madeline Sterling; Jeffrey R Curtis; Lisa A Mandl; Iris Navarro-Millán
Journal:  Semin Arthritis Rheum       Date:  2021-01-05       Impact factor: 5.532

3.  Dementia Care in Diverse Older Adults in the U.S. Deep South and the Rest of the United States.

Authors:  Maria Pisu; Roy C Martin; Liang Shan; Giovanna Pilonieta; Richard E Kennedy; Gabriela Oates; Young-Il Kim; David S Geldmacher
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

4.  Pharmaceutical Treatment for Alzheimer's Disease and Related Dementias: Utilization and Disparities.

Authors:  Douglas Barthold; Geoffrey Joyce; Patricia Ferido; Emmanuel F Drabo; Zachary A Marcum; Shelly L Gray; Julie Zissimopoulos
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

5.  Suicide risk in first year after dementia diagnosis in older adults.

Authors:  Timothy Schmutte; Mark Olfson; Donovan T Maust; Ming Xie; Steven C Marcus
Journal:  Alzheimers Dement       Date:  2021-05-25       Impact factor: 21.566

6.  Cognitive Decline and Dementia Risk Reduction: Promoting Healthy Lifestyles and Blood Pressure Control.

Authors:  John P Barrett; Benjamin S Olivari; Andrea B Price; Christopher A Taylor
Journal:  Am J Prev Med       Date:  2021-05-15       Impact factor: 6.604

7.  Documentation of Dementia as a Cause of Death Among Mexican-American Decedents Diagnosed with Dementia.

Authors:  Brian Downer; Lin-Na Chou; Soham Al Snih; Cheyanne Barba; Yong-Fang Kuo; Mukaila Raji; Kyriakos S Markides; Kenneth J Ottenbacher
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 8.  Drug therapies for chronic conditions and risk of Alzheimer's disease and related dementias: A scoping review.

Authors:  Johanna Thunell; Yi Chen; Geoffrey Joyce; Douglas Barthold; Paul G Shekelle; Roberta Diaz Brinton; Julie Zissimopoulos
Journal:  Alzheimers Dement       Date:  2020-10-08       Impact factor: 21.566

9.  Dementia Diagnosis Disparities by Race and Ethnicity.

Authors:  Pei-Jung Lin; Allan T Daly; Natalia Olchanski; Joshua T Cohen; Peter J Neumann; Jessica D Faul; Howard M Fillit; Karen M Freund
Journal:  Med Care       Date:  2021-08-01       Impact factor: 3.178

Review 10.  Impact of dementia: Health disparities, population trends, care interventions, and economic costs.

Authors:  María P Aranda; Ian N Kremer; Ladson Hinton; Julie Zissimopoulos; Rachel A Whitmer; Cynthia Huling Hummel; Laura Trejo; Chanee Fabius
Journal:  J Am Geriatr Soc       Date:  2021-07       Impact factor: 7.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.